Webinars

Speaker: Dr. Haluk Topaloglu When: Saturday, May 31, 2025 Time: 9:00 AM EST About Topic: Paintings of children as the centre of attention or theme, from different periods and cultures in time, from thousands of years BC up until our contemporary times.

Speaker: Pr Kumaran Deiva When: Mercredi, Mai 21, 2025 Time: 7 PM CEST About Topic: La SEP de l’enfant est reconnue de plus en plus précocement grâce à l'amélioration des critères diagnostiques (2017 IPMSSG). Les traitements de fond utilisés chez l’adulte sont désormais validés chez l’enfant : le fingolimod a été le premier approuvé pour les formes pédiatriques récurrentes. D’autres biothérapies comme le natalizumab ou l’ocrelizumab sont utilisées hors AMM avec des résultats prometteurs. La prise en charge actuelle repose sur une approche précoce, individualisée et multidisciplinaire, intégrant neurologie,...

Speaker: Dr Mark Gorman, MD When: Saturday, May 10, 2025 Time: 09:00 AM Eastern Time ( US/ Canada ) About Topic: Opsoclonus myoclonus ataxia syndrome is a rare neuro-immunological disorder affecting the cerebellum. In children, the average age of onset is 18 to 24 months, and 50-60% of patients have a neuroblastoma as part of a paraneoplastic process. Due to its rarity, severity and lack of a definitive biomarker, numerous challenges exist, including delayed diagnosis, variation in treatment approaches, and historically poor cognitive and behavioral outcomes. However, significant progress has been made...

Speaker: Dr Caroline Sevin; When: April 18, 2025; Time: 6 pm CET (7 pm CEST); About Topic: This Webinar will focus on X-linked adrenoleukodystrophy (ALD), a genetic disorder affecting the nervous system and the most frequent leukodystrophy in children and males. We will discuss clinical symptoms, underlying molecular mechanisms and therapeutic approaches. We will also highlight the crucial role of early screening for early detection, enabling timely intervention and the importance of continuous follow-up to monitor disease progression and the effectiveness of emerging treatments. Learning Objective: ...

Neurology Through Art & Time; Speaker: Natalie Erlich-Malona; When: Saturday, April 26, 2026; Time: 9:00 - 10:00 AM Eastern Time ( US / Canada ) Learning Objectives: o To understand the origins of the “Mozart Effect” o To become familiar with the scientific evidence for an effect of Mozart listening on interictal EEG and clinical seizure frequency o To understand the potential for the widespread use of music therapy as an adjunctive treatment for drug-resistant epilepsy.

Speaker: Dr (Col) Aneesh Mohimen When: Saturday, April 12, 2025 Time: 09:00 AM Eastern Time ( US/ Canada ) About Topic: Case-based approach for diagnosis and management of Pediatric Intra-cranial hemorrhage across age groups. Discussion on common and uncommon clinico-radiological situations with special emphasis on practice of tropical pediatric neuroradiology. The lecture will start from neonatal hemorrhage and extend to older children till adolescent age groups. Learning Objectives : Etiological aspects and imaging of pediatric intracranial hemorrhage across age groups. Special...

Speaker: Phillip Pearl When: Saturday, March 29, 2025 Time: 09 AM EST Topic: Music and Autism Spectrum Disorder Phillip L. Pearl, M.D. is Director of Epilepsy and Clinical Neurophysiology at Boston Children’s Hospital and William G. Lennox Chair and Professor of Neurology at Harvard Medical School. Dr. Pearl, originally from Baltimore, attended Johns Hopkins University and Peabody Conservatory of Music and the University of Maryland School of Medicine. He did his residency at Baylor College of Medicine in Houston and fellowship at Boston Children’s Hospital. He was Division Chief of Neurology at Children’s National Medical Center and Professor...

Speaker: Pr Seraphin Nguefack When: Thursday, March 20, 2025 Time: 4 pm (CET) About Topic: Psychomotor delay is a frequent reason for consultation in paediatric neurology. The causes can be acquired or innate and be responsible for fixed or progressive psychomotor delay. One of the primary aetiologies of psychomotor delay in our context is perinatal asphyxia with anoxo-ischemic encephalopathy. Access to genetic and molecular investigations still remains difficult in our context. Management is essentially symptomatic. Prevention is the key to treatment for preventable causes Learning Objectives: o Define psychomotor delay in children o Describe...

Speaker: Juliana Gurgel Giannetti When: Saturday, March 8, 2025 Time: 09:00 AM Eastern Time ( US/ Canada ) About Topic: Over the last decade, several therapeutic approaches have been developed for different Neuromuscular disorders, and SMA5q is the main example in this field. In the past, SMA5q was considered one of the most common lethal genetic disorders in childhood. Currently, there are three medications for SMA5q approved by the Food and Drug Administration (FDA) and in several countries (Nusinsersen, Onasemnogene Abeparvovec and Risdiplam), which can change the natural history of this disorder with the...

Speaker: Tipu Sultan When: Saturday, February 8, 2025 Time: 09:00 AM Eastern Time ( US/ Canada ) About Topic: Central nervous system inflammatory disorders are always diagnostic challenges due to wide differential diagnosis. Newly recognized anti-neuronal antibody-mediated disorders such as anti-N-methyl-D-aspartate receptor (NMDA) encephalitis have become an important diagnostic consideration in children presenting with severe newly acquired neuropsychiatric symptoms. The clinical course of anti-NMDA-receptor antibody encephalitis is preceded by a nonspecific prodromal stage leading to psychiatric symptoms or abnormal movements. Prompt recognition and treatment may reverse the condition, hastening recovery and limiting neurological morbidity....